Google
Trusted Resources: News & Events
Latest announcements and gatherings
Only 21% of Kids with ADHD and SCD Are Treated for Attention Deficit
A study of children with sickle cell disease (SCD) referred for an evaluation of neuropsychological deficits found that while 19 of 89 patients (25%) were diagnosed with attention deficit hyperactivity disorder (ADHD), only 21% with ADHD had been prescribed medication for it.
The study, “Attention Deficit Hyperactivity Disorder in Children With Sickle Cell Disease Referred for an Evaluation,” was published in the Journal of Pediatric Hematology/Oncology.
+myBinderRelated Content
-
Adverse Pregnancy Outcomes in Women With Sickle Cell TraitObjective: To compare adverse pregnancy...
-
Study challenges view that sickle cell trait increases mortality riskSurprising findings from a study of heal...
-
A Comparison of an Individualized and Weight-Based Opioid Protocols for the Treatment of Vaso-Occlusive Episodes in ...Introduction: Vaso-occlusive episodes ar...
-
How sickled red blood cells stick to blood vesselsOne of the most common complications o...
-
Black Americans With Sickle Cell Trait At Increased Risk Of Kidney DiseaseAfrican Americans with sickle cell trait...
-
Vaso occlusive Crisis Pain Assessment & Managementhttps://www.youtube.com/watch?time_conti...
-
A Man With Sickle Cell Disease and HeadacheApproximately 17% of patients with sickl...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.